Related Products
AIMOVIG 70 MG / 1 ML INJECTION
Aimovig Components
Aimovig contains erinumab, a human immunoglobulin G2, or monoclonal antibody produced using recombinant DNA technology, and has a high affinity to CGRP receptors.
Aimovig injection uses
Aimovig injection is used to prevent migraines.
Aimovig dosage
- The appropriate is determined by the doctor.
- The recommended dose is 70 mg once every 4 weeks.
- Aimovig is used by subcutaneous injections.
- The need for treatment should be reassessed in regular periods of 3-6 months.
- The effectiveness and safety of the drug for those suffering from migraines less than 4 times a month has not been assessed.
Aimovig Side Effects
Aimovig may cause some side effects, such as:
- Constipation.
- Nausea and vomiting.
- Fatigue.
- erythema and pain in the injection site.
- respiratory infection.
- dizziness.
- Insomnia.
- Muscle spasm.
- Pruritus.
Aimovig contraindications
Aimovig is not used in case of allergies to its ingredients.
Aimovig use precautions
The doctor should be consulted before using Aimovig, especially in the following cases:
- Constipation.
- High blood pressure.
- Pregnancy and lactation.
Translation missing: en.general.search.loading